Properties (64)
Predicate | Object |
---|---|
gptkbp:instanceOf |
chemical compound
|
gptkbp:chemicalFormula |
C12H15N3O2
|
gptkbp:hasAwards |
serotonin receptors
|
gptkbp:hasFilm |
dizziness
nausea |
gptkbp:hasWeight |
219.27 g/mol
|
https://www.w3.org/2000/01/rdf-schema#label |
WPC-1151
|
gptkbp:isAssociatedWith |
serotonin syndrome
|
gptkbp:isAttendedBy |
gptkb:FDA
oral tablet other antidepressants |
gptkbp:isAvailableIn |
various dosages
|
gptkbp:isAvenueFor |
efficacy
safety profile |
gptkbp:isChallengedBy |
liver enzymes
|
gptkbp:isCompatibleWith |
high stability under normal conditions
|
gptkbp:isConsidered |
alternative therapy
first-line treatment off-label use psychotropic medication |
gptkbp:isDiscussedIn |
medical literature
patient education materials healthcare_professionals |
gptkbp:isDocumentedIn |
clinical trials registry
|
gptkbp:isEvaluatedBy |
quality of life improvement
treatment-resistant depression |
gptkbp:isExemplifiedBy |
urine
|
gptkbp:isKnownFor |
improving mood
reducing anxiety |
gptkbp:isLinkedTo |
withdrawal symptoms
weight gain sexual dysfunction |
gptkbp:isMarketedAs |
brand name A
|
gptkbp:isPartOf |
research studies
clinical trials mental health treatment treatment protocols placebo mental health guidelines other antidepressants mental health pharmacotherapy |
gptkbp:isPortrayedBy |
medical journals
|
gptkbp:isRecognizedFor |
long-term use
|
gptkbp:isRelatedTo |
antidepressants
|
gptkbp:isStudiedIn |
depression
animal models cognitive function sleep disorders anxiety disorders |
gptkbp:isSubjectTo |
clinical guidelines
|
gptkbp:isSuitableFor |
precursor compounds
|
gptkbp:isUsedIn |
pharmaceuticals
clinical psychology psychopharmacology |
gptkbp:isUtilizedFor |
neurodegenerative diseases
bipolar disorder chronic pain management obsessive-compulsive disorder |
gptkbp:isUtilizedIn |
randomized controlled trials
meta-analyses |
gptkbp:isVisitedBy |
gptkb:XYZ_Pharmaceuticals
|
gptkbp:numberOfFigures |
123456-78-9
|
gptkbp:training |
liver disease
pregnancy |